First Quadrant’s Natus Medical Inc NTUS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-12,149
Closed -$243K 629
2020
Q4
$243K Sell
12,149
-26,700
-69% -$523K 0.02% 338
2020
Q3
$665K Sell
38,849
-13,325
-26% -$252K 0.08% 187
2020
Q2
$1.14M Sell
52,174
-7,301
-12% -$167K 0.15% 156
2020
Q1
$1.38M Sell
59,475
-11,257
-16% -$327K 0.2% 129
2019
Q4
$2.33M Buy
+70,732
New +$2.27M 0.2% 109
2015
Q4
Sell
-10,600
Closed -$418K 856
2015
Q3
$418K Sell
10,600
-10,600
-50% -$450K 0.01% 474
2015
Q2
$902K Hold
21,200
0.02% 384
2015
Q1
$837K Hold
21,200
0.02% 381
2014
Q4
$764K Buy
21,200
+3,700
+21% +$124K 0.02% 394
2014
Q3
$516K Buy
+17,500
New +$483K 0.01% 456

Other funds holding NTUS

First Quadrant's NTUS Position: Q1 2021 in Review

First Quadrant sold out of Natus Medical Inc (NTUS) in Q1 2021, closing a stake of 12,149 shares — an estimated $243K sold.

First Quadrant first reported a position in NTUS in Q3 2014 and held it in 10 quarters. The position peaked at $2.33M in Q4 2019. 156 funds tracked by Wall St. Rank hold NTUS as of Q1 2021.

  • First Quadrant reported no remaining Natus Medical Inc position as of Q1 2021 after selling out during the quarter.
  • First Quadrant sold 12,149 Natus Medical Inc shares in Q1 2021, an estimated $243K.
  • First Quadrant first reported a position in Natus Medical Inc in Q3 2014 and held it in 10 quarters.
  • First Quadrant's Natus Medical Inc position peaked at $2.33M in Q4 2019.
  • 156 funds tracked by Wall St. Rank held Natus Medical Inc as of Q1 2021.

Based on First Quadrant's 13F filing for Q1 2021, filed 27 Apr 2021.